SCHEMBL6937524

SCHEMBL6937524

Cc1cn2ccnc(O)c2n1

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
TNKS O95271 1/20 0.33
NUDT1 P36639 1/20 0.32
HCRTR2 O43614 10/20 0.32
HCRTR1 O43613 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15688602 0.85 L3MBTL1 (0.44) L3MBTL1TNKSNUDT1HCRTR2HCRTR1
SCHEMBL21863368 0.80 L3MBTL1 (0.43) L3MBTL1TNKSNUDT1HCRTR2HCRTR1
SCHEMBL25095788 0.77 PIK3R1 (0.35) ALDH1A1HPGDHSD17B10
SCHEMBL9080834 0.77 NUDT1 (0.55) L3MBTL1TNKSNUDT1ALDH1A1HPGD
SCHEMBL2179459 0.77 L3MBTL1 (0.41) L3MBTL1TNKSNUDT1HCRTR2ALDH1A1
SCHEMBL15687846 0.76 L3MBTL1 (0.47) L3MBTL1TNKSNUDT1HCRTR2HCRTR1
Bromide SCHEMBL17873904 0.76 L3MBTL1 (0.40) L3MBTL1TNKSNUDT1ALDH1A1HPGD
SCHEMBL19554927 0.75 MGLL (0.38) L3MBTL1HCRTR2HCRTR1ALDH1A1
SCHEMBL21848969 0.74 L3MBTL1 (0.39) L3MBTL1TNKSNUDT1HCRTR2
SCHEMBL21848955 0.74 L3MBTL1 (0.39) L3MBTL1TNKSNUDT1HCRTR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2917219-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS Pfizer Inc. (US) 2015-09-16 EP disclosed
WO-2014072881-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS PFIZER INC. (US) 2014-05-15 WO disclosed
WO-2011110545-A1 IMIDAZO [1, 2 -A] PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES JANSSEN PHARMACEUTICA NV (BE) 2011-09-15 WO disclosed